BECHTLE AG (BC8.DE) Fundamental Analysis & Valuation

FRA:BC8 • DE0005158703

33.52 EUR
+0.3 (+0.9%)
Last: Mar 6, 2026, 07:00 PM

This BC8.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

BC8 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 75 industry peers in the IT Services industry. BC8 has an excellent financial health rating, but there are some minor concerns on its profitability. While showing a medium growth rate, BC8 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. BC8.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BC8 was profitable.
  • In the past year BC8 had a positive cash flow from operations.
  • BC8 had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BC8 had a positive operating cash flow.
BC8.DE Yearly Net Income VS EBIT VS OCF VS FCFBC8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

  • BC8 has a Return On Assets (5.25%) which is comparable to the rest of the industry.
  • With a Return On Equity value of 10.97%, BC8 perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
  • BC8 has a Return On Invested Capital (8.29%) which is in line with its industry peers.
  • BC8 had an Average Return On Invested Capital over the past 3 years of 12.02%. This is in line with the industry average of 11.55%.
Industry RankSector Rank
ROA 5.25%
ROE 10.97%
ROIC 8.29%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
BC8.DE Yearly ROA, ROE, ROICBC8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • BC8 has a Profit Margin (3.39%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of BC8 has grown nicely.
  • With a Operating Margin value of 4.89%, BC8 perfoms like the industry average, outperforming 44.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BC8 has grown nicely.
  • Looking at the Gross Margin, with a value of 18.07%, BC8 is doing worse than 81.33% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BC8 has grown nicely.
Industry RankSector Rank
OM 4.89%
PM (TTM) 3.39%
GM 18.07%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
BC8.DE Yearly Profit, Operating, Gross MarginsBC8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

7

2. BC8.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BC8 is creating value.
  • The number of shares outstanding for BC8 remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, BC8 has about the same amount of shares outstanding.
  • BC8 has a better debt/assets ratio than last year.
BC8.DE Yearly Shares OutstandingBC8.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BC8.DE Yearly Total Debt VS Total AssetsBC8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • BC8 has an Altman-Z score of 3.87. This indicates that BC8 is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of BC8 (3.87) is better than 81.33% of its industry peers.
  • BC8 has a debt to FCF ratio of 1.84. This is a very positive value and a sign of high solvency as it would only need 1.84 years to pay back of all of its debts.
  • BC8 has a Debt to FCF ratio of 1.84. This is in the better half of the industry: BC8 outperforms 74.67% of its industry peers.
  • BC8 has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • BC8's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. BC8 outperforms 72.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.84
Altman-Z 3.87
ROIC/WACC1.26
WACC6.59%
BC8.DE Yearly LT Debt VS Equity VS FCFBC8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.68 indicates that BC8 should not have too much problems paying its short term obligations.
  • The Current ratio of BC8 (1.68) is better than 76.00% of its industry peers.
  • BC8 has a Quick Ratio of 1.39. This is a normal value and indicates that BC8 is financially healthy and should not expect problems in meeting its short term obligations.
  • BC8's Quick ratio of 1.39 is fine compared to the rest of the industry. BC8 outperforms 73.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.39
BC8.DE Yearly Current Assets VS Current LiabilitesBC8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. BC8.DE Growth Analysis

3.1 Past

  • The earnings per share for BC8 have decreased strongly by -14.07% in the last year.
  • The Earnings Per Share has been growing slightly by 7.58% on average over the past years.
  • BC8 shows a decrease in Revenue. In the last year, the revenue decreased by -0.50%.
  • Measured over the past years, BC8 shows a small growth in Revenue. The Revenue has been growing by 3.25% on average per year.
EPS 1Y (TTM)-14.07%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%2.27%
Revenue 1Y (TTM)-0.5%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%5.09%

3.2 Future

  • Based on estimates for the next years, BC8 will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.43% on average per year.
  • BC8 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.11% yearly.
EPS Next Y-5.37%
EPS Next 2Y4.36%
EPS Next 3Y6.37%
EPS Next 5Y9.43%
Revenue Next Year1.5%
Revenue Next 2Y3.88%
Revenue Next 3Y4.85%
Revenue Next 5Y4.11%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BC8.DE Yearly Revenue VS EstimatesBC8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BC8.DE Yearly EPS VS EstimatesBC8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

3

4. BC8.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.60, the valuation of BC8 can be described as rather expensive.
  • BC8's Price/Earnings is on the same level as the industry average.
  • BC8 is valuated rather cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 15.78, BC8 is valued correctly.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BC8.
  • BC8's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.57.
Industry RankSector Rank
PE 19.6
Fwd PE 15.78
BC8.DE Price Earnings VS Forward Price EarningsBC8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BC8 is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BC8 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 14.07
EV/EBITDA 8.9
BC8.DE Per share dataBC8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.59
EPS Next 2Y4.36%
EPS Next 3Y6.37%

4

5. BC8.DE Dividend Analysis

5.1 Amount

  • BC8 has a Yearly Dividend Yield of 2.11%.
  • In the last 3 months the price of BC8 has falen by -22.87%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 2.52, BC8 has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, BC8 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.11%

5.2 History

  • On average, the dividend of BC8 grows each year by 16.00%, which is quite nice.
Dividend Growth(5Y)16%
Div Incr Years1
Div Non Decr Years6
BC8.DE Yearly Dividends per shareBC8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • BC8 pays out 40.98% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of BC8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP40.98%
EPS Next 2Y4.36%
EPS Next 3Y6.37%
BC8.DE Yearly Income VS Free CF VS DividendBC8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
BC8.DE Dividend Payout.BC8.DE Dividend Payout, showing the Payout Ratio.BC8.DE Dividend Payout.PayoutRetained Earnings

BC8.DE Fundamentals: All Metrics, Ratios and Statistics

BECHTLE AG

FRA:BC8 (3/6/2026, 7:00:00 PM)

33.52

+0.3 (+0.9%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-14
Earnings (Next)03-20
Inst Owners40.71%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap4.22B
Revenue(TTM)6.35B
Net Income(TTM)215.25M
Analysts81.82
Price Target45.84 (36.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.11%
Yearly Dividend0.7
Dividend Growth(5Y)16%
DP40.98%
Div Incr Years1
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.1%
Min EPS beat(2)-5.27%
Max EPS beat(2)9.48%
EPS beat(4)1
Avg EPS beat(4)-1.86%
Min EPS beat(4)-9.37%
Max EPS beat(4)9.48%
EPS beat(8)2
Avg EPS beat(8)-3.08%
EPS beat(12)3
Avg EPS beat(12)-1.94%
EPS beat(16)6
Avg EPS beat(16)-0.67%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)0.9%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.25%
Max Revenue beat(4)0.9%
Revenue beat(8)3
Avg Revenue beat(8)-2.73%
Revenue beat(12)5
Avg Revenue beat(12)-0.16%
Revenue beat(16)7
Avg Revenue beat(16)-3.75%
PT rev (1m)-0.48%
PT rev (3m)2.22%
EPS NQ rev (1m)-2.8%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.17%
Revenue NQ rev (1m)-2.17%
Revenue NQ rev (3m)-2.37%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-1.98%
Valuation
Industry RankSector Rank
PE 19.6
Fwd PE 15.78
P/S 0.66
P/FCF 14.07
P/OCF 10.11
P/B 2.15
P/tB 4.8
EV/EBITDA 8.9
EPS(TTM)1.71
EY5.1%
EPS(NY)2.12
Fwd EY6.34%
FCF(TTM)2.38
FCFY7.11%
OCF(TTM)3.32
OCFY9.89%
SpS50.42
BVpS15.57
TBVpS6.98
PEG (NY)N/A
PEG (5Y)2.59
Graham Number24.48
Profitability
Industry RankSector Rank
ROA 5.25%
ROE 10.97%
ROCE 11.68%
ROIC 8.29%
ROICexc 10.25%
ROICexgc 20.62%
OM 4.89%
PM (TTM) 3.39%
GM 18.07%
FCFM 4.72%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
ROICexc(3y)15.84%
ROICexc(5y)15.71%
ROICexgc(3y)29.63%
ROICexgc(5y)28.23%
ROCE(3y)16.94%
ROCE(5y)16.89%
ROICexgc growth 3Y4.87%
ROICexgc growth 5Y7.72%
ROICexc growth 3Y-3.54%
ROICexc growth 5Y2.28%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.84
Debt/EBITDA 0.86
Cap/Depr 75.08%
Cap/Sales 1.85%
Interest Coverage 13.03
Cash Conversion 89.38%
Profit Quality 139.44%
Current Ratio 1.68
Quick Ratio 1.39
Altman-Z 3.87
F-Score5
WACC6.59%
ROIC/WACC1.26
Cap/Depr(3y)72%
Cap/Depr(5y)67.96%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.35%
Profit Quality(3y)113.31%
Profit Quality(5y)113.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.07%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%2.27%
EPS Next Y-5.37%
EPS Next 2Y4.36%
EPS Next 3Y6.37%
EPS Next 5Y9.43%
Revenue 1Y (TTM)-0.5%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%5.09%
Revenue Next Year1.5%
Revenue Next 2Y3.88%
Revenue Next 3Y4.85%
Revenue Next 5Y4.11%
EBIT growth 1Y-13.29%
EBIT growth 3Y6.14%
EBIT growth 5Y10.1%
EBIT Next Year36.78%
EBIT Next 3Y17.04%
EBIT Next 5Y9.19%
FCF growth 1Y-31.78%
FCF growth 3Y27.55%
FCF growth 5Y27.87%
OCF growth 1Y-22.28%
OCF growth 3Y25.19%
OCF growth 5Y24.58%

BECHTLE AG / BC8.DE FAQ

Can you provide the ChartMill fundamental rating for BECHTLE AG?

ChartMill assigns a fundamental rating of 5 / 10 to BC8.DE.


What is the valuation status for BC8 stock?

ChartMill assigns a valuation rating of 3 / 10 to BECHTLE AG (BC8.DE). This can be considered as Overvalued.


How profitable is BECHTLE AG (BC8.DE) stock?

BECHTLE AG (BC8.DE) has a profitability rating of 5 / 10.


What is the valuation of BECHTLE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BECHTLE AG (BC8.DE) is 19.6 and the Price/Book (PB) ratio is 2.15.


Can you provide the financial health for BC8 stock?

The financial health rating of BECHTLE AG (BC8.DE) is 7 / 10.